Alzheimer disease biomarker testing in cerebrospinal fluid: A method to harmonize assay platforms in the absence of an absolute reference standard

Clinical Chemistry

Volumn 59, Issue 4, 2013, Pages 710-712

  Vanderstichele, Hugo Marcel ^a,b,i   Shaw, Leslie ^c   Vandijck, Manu ^b   Jeromin, Andreas ^d   Zetterberg, Henrik ^e,f   Blennow, Kaj ^f   Teunissen, Charlotte ^g   Engelborghs, Sebastiaan ^h  

^a Rogers BVBA   (Belgium)

^b INNOGENETICS   (Belgium)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NextGen Sciences Dx   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF ANTWERP   (Belgium)

ⁱ not available   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BINDING AFFINITY; CALIBRATOR; CEREBROSPINAL FLUID ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LETTER; QUALITY CONTROL; STANDARD; VALIDATION PROCESS;

EID: 84875841347     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.201830     Document Type: Letter

References (5)

1. Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement 2012;8:65-73.
2. Andreasson U, Vanmechelen E, Shaw LM, Zetterberg H, Vanderstichele H. Analytical aspects of molecular Alzheimer's disease biomarkers. Biomark Med 2012;6:377-89.
3. Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, et al. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging 2008;29:1143-59.
4. Vanderstichele H, De Meyer G, Shapiro F, Engelborghs B, Shaw L, Torjanowski J. Alzheimer's disease biomarkers: from concept to clinical utility. In: Galimberti D, Scarpini E, eds. Biomarkers for early diagnosis of Alzheimer's disease. Hauppauge, New York: Nova Science Publishers; 2008. p 81-122.
5. Petersen PH, Stöckl D, Blaabjerg O, Pedersen B, Birkemose E, Thienpont L, et al. Graphical interpretation of analytical data from comparison of a field method with a reference method by use of difference plots. Clin Chem 1997;43:2039-46.